Health Condition 1: R52- Pain, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the patients presenting with acute pain. 2. Patients of all age group and both sexes. 3. Patients taking a prescription medication (NSAIDs, acetaminophen, and aspirin) episodically (or as needed) for the management of pain, agrees to discontinue its use prior to or at the Screening and Baseline Visit 4. Patients agreeing to not commence any new prescription medication for the management of pain throughout the study 5. Patients agreeing to not commence any injection therapy for pain during the course of the study 6. Patients agreeing to not use acupuncture, biofeedback, or transcutaneous electrical nerve stimulation (TENS) for the management of pain during the course of the study.
Exclusion criteria
Exclusion criteria: 1. Terminally ill patients. [eg. congestive heart failure, renal failure or dialysis etc.] 2. Patients unwilling to give the consent. 3. Patients with pre-existing opiate therapy; and patients with dependencies on tobacco, alcohol, opioids, or other substances. 4. Patients with angina, bronchospasm, bronchial asthma, bronchospasm (chronic obstructive pulmonary disease and emphysema), diabetes mellitus, hyperthyroidism, fibromyalgia, or uncontrolled seizures or known hypersensitivity. 5. Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participantââ?¬•s full compliance with or completion of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale (VAS) measuring pain intensityTimepoint: Visual Analogue Scale (VAS) at Baseline And After 1 week of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Health-related quality of life (HRQOL)Timepoint: Health-related quality of life (HRQOL) at Baseline & after 1 week of intervention | — |
Countries
India
Contacts
Sri Ganganagar Homoeopathic Medical College Hospital and Research Institute